'Some Hope Is Better Than Having No Hope'

Over the weekend, Jensen Huang, the chief executive and co-founder of Nvidia — which makes the chips that power artificial intelligence — admitted to having an affair with a woman who has been determined by U.S. officials to be a spy. That revelation came after The New York Times ...  Show more

After a stinging rebuke last week at the polls, President Trump announced that he would elevate Stephen Miller — a driving force behind some of the most polarizing policies of Mr. Trump’s second term — to chief of staff.Maggie Haberman and Jonathan Swan, White House reporters for ...  Show more

The FDA has approved a new drug for Alzheimer's. But a lot of experts are skeptical about whether the drug works. Rhitu Chatterjee talks with science correspondent Jon Hamilton about the controversial drug aducanumab and why the U.S. Food and Drug Administration approved it. For ...  Show more

A new drug for Alzheimer's disease, called lecanemab, got a lot of attention earlier this year for getting fast-tracked approval based on a clinical trial that included nearly 1,800 people. It was the most diverse trial for an Alzheimer's treatment to date, but still not enough t ...  Show more

After decades without progress, this June a new treatment was approved by the US Food and Drugs Administration - Biogen's Aduhelm. Ivana Davidovic looks into why this process has been so controversial that is now under investigation by a federal watchdog.Aaron Kesselheim, a Harva ...  Show more